$22.95
7.35% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US86881A1007
Symbol
SGRY

Surgery Partners, Inc. Target price 2024 - Analyst rating & recommendation

Surgery Partners, Inc. Classifications & Recommendation:

Buy
75%
Hold
25%

Surgery Partners, Inc. Price Target

Target Price $38.09
Price $22.95
Potential
Number of Estimates 11
11 Analysts have issued a price target Surgery Partners, Inc. 2025 . The average Surgery Partners, Inc. target price is $38.09. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 9 Analysts recommend Surgery Partners, Inc. to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Surgery Partners, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Surgery Partners, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 2.74 3.08
8.03% 12.28%
EBITDA Margin 19.20% 16.53%
3.95% 13.89%
Net Margin -0.42% -0.15%
85.88% 64.04%

10 Analysts have issued a sales forecast Surgery Partners, Inc. 2024 . The average Surgery Partners, Inc. sales estimate is

$3.1b
Unlock
. This is
3.18% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.1b 3.48%
Unlock
, the lowest is
$3.1b 3.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $2.7b 8.03%
2024
$3.1b 12.28%
Unlock
2025
$3.4b 9.99%
Unlock
2026
$3.7b 9.34%
Unlock
2027
$4.1b 11.23%
Unlock

10 Analysts have issued an Surgery Partners, Inc. EBITDA forecast 2024. The average Surgery Partners, Inc. EBITDA estimate is

$509m
Unlock
. This is
12.50% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$512m 12.02%
Unlock
, the lowest is
$508m 12.75%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $527m 3.76%
2024
$509m 3.30%
Unlock
2025
$571m 12.13%
Unlock
2026
$644m 12.73%
Unlock
2027
$736m 14.35%
Unlock

EBITDA Margin

2023 19.20% 3.95%
2024
16.53% 13.89%
Unlock
2025
16.85% 1.94%
Unlock
2026
17.38% 3.15%
Unlock
2027
17.87% 2.82%
Unlock

6 Surgery Partners, Inc. Analysts have issued a net profit forecast 2024. The average Surgery Partners, Inc. net profit estimate is

$-4.7m
Unlock
. This is
92.25% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$52.9m 186.74%
Unlock
, the lowest is
$-38.1m 37.50%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-11.4m 84.75%
2024
$-4.7m 58.66%
Unlock
2025
$99.7m 2,208.67%
Unlock
2026
$125m 25.01%
Unlock
2027
$179m 43.77%
Unlock

Net Margin

2023 -0.42% 85.88%
2024
-0.15% 64.04%
Unlock
2025
2.94% 2,060.00%
Unlock
2026
3.37% 14.63%
Unlock
2027
4.35% 29.08%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.09 -0.04
84.75% 55.56%
P/E negative
EV/Sales 2.55

6 Analysts have issued a Surgery Partners, Inc. forecast for earnings per share. The average Surgery Partners, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.04
Unlock
. This is
91.67% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.42 187.50%
Unlock
, the lowest is
$-0.30 37.50%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.09 84.75%
2024
$-0.04 55.56%
Unlock
2025
$0.78 2,050.00%
Unlock
2026
$0.98 25.64%
Unlock
2027
$1.41 43.88%
Unlock

P/E ratio

Current -47.76 41.78%
2024
-616.55 1,190.93%
Unlock
2025
29.25 104.74%
Unlock
2026
23.40 20.00%
Unlock
2027
16.28 30.43%
Unlock

Based on analysts' sales estimates for 2024, the Surgery Partners, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.64 2.58%
2024
2.55 3.26%
Unlock
2025
2.32 9.08%
Unlock
2026
2.12 8.54%
Unlock
2027
1.91 10.10%
Unlock

P/S ratio

Current 0.98 19.88%
2024
0.95 3.08%
Unlock
2025
0.86 9.08%
Unlock
2026
0.79 8.55%
Unlock
2027
0.71 10.10%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today